Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV

NCT00266526 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Birch Pollen Allergy

Interventions

BIOLOGICAL: Recombinant birch pollen

Sponsor

Allergopharma GmbH & Co. KG